Hepatocellular carcinoma recurrence after directly-acting antiviral therapy: caution with hepatitis C

被引：0
|
作者：
Ng, Alexander [1 ]
机构：
[1] UCL, Fac Laws, Gower St, London WC1E 6BT, England
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2021年 / 33卷
关键词：
D O I：
10.1097/MEG.0000000000002193
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E1091 / E1092
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of directly-acting antiviral therapy for chronic hepatitis C virus in elderly people
    De Santis, Adriano
    Maggi, Daniela
    Lobianco, Federica Lubrano
    AGING MEDICINE, 2021, 4 (04) : 304 - 316
  • [2] Changing Trends of Cirrhotic and Noncirrhotic Hepatocellular Carcinoma in the Era of Directly-Acting Antiviral Agents
    Mathur, Karan
    Mazhar, Areej
    Patel, Milin
    Dakhoul, Lara
    Burney, Heather
    Liu, Hao
    Nephew, Lauren
    Chalasani, Naga
    deLemos, Andrew
    Gawrieh, Samer
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (11) : E00420
  • [3] Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma
    Yang, Ju Dong
    Aqel, Bashar A.
    Pungpapong, Surakit
    Gores, Gregory J.
    Roberts, Lewis R.
    Leise, Michael D.
    JOURNAL OF HEPATOLOGY, 2016, 65 (04) : 859 - 860
  • [4] Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
    Lee, Chang Hun
    Kim, In Hee
    GUT AND LIVER, 2021, 15 (03) : 327 - 328
  • [5] Tumour progression and recurrence after direct acting antiviral therapy for hepatitis C in patients with previously treated or active hepatocellular carcinoma
    Wong, M.
    Mccaughan, G.
    Mason, S.
    Moore, B.
    Bowen, D.
    Koorey, D.
    Strasser, S.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S418 - S418
  • [6] Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C
    Ahn, Young-Hwan
    Lee, Heirim
    Kim, Do Young
    Lee, Hye Won
    Yu, Su Jong
    Cho, Young Youn
    Jang, Jeong Won
    Jang, Byoung Kuk
    Kim, Chang Wook
    Kim, Hee Yeon
    Park, Hana
    Cho, Hyo Jung
    Park, Bumhee
    Kim, Soon Sun
    Cheong, Jae Youn
    GUT AND LIVER, 2021, 15 (03) : 410 - 419
  • [7] Decreased Incidence of Hepatocellular Carcinoma after Directly Acting Antiviral Therapy in Patients with Hepatitis C-Related Advanced Fibrosis and Cirrhosis
    Kilany, Shimaa
    Ata, Lmyaa
    Gomaa, Asmaa
    Sabry, Aliaa
    Nada, Ali
    Tharwa, El-Sayed
    Badra, Gamal
    Abogabal, Ashraf
    Elwaraky, Mohamed
    Moaz, Enas
    Ezzat, Sameera
    Elsharawy, Ahmed
    Waked, Imam
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 925 - 935
  • [8] Emerging resistance to directly-acting antiviral therapy in treatment of chronic Hepatitis C infection-A brief review of literature
    Bhatia, Mohit
    Gupta, Ekta
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2020, 9 (02) : 531 - 538
  • [9] Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C
    Kawagishi, Naoki
    Suda, Goki
    Yamamoto, Yoshiya
    Baba, Masaru
    Furuya, Ken
    Maehara, Osamu
    Ohnishi, Shunsuke
    Yoshida, Sonoe
    Fu, Qingjie
    Yang, Zijian
    Hosoda, Shunichi
    Tokuchi, Yoshimasa
    Kitagataya, Takashi
    Ohara, Masatsugu
    Suzuki, Kazuharu
    Nakai, Masato
    Sho, Takuya
    Natsuizaka, Mitsuteru
    Ogawa, Koji
    Sakamoto, Naoya
    VIRUSES-BASEL, 2023, 15 (01):
  • [10] Hepatocellular carcinoma recurrence after curative treatments in patients with chronic hepatitis C who underwent direct-acting antiviral therapy
    Minami, Tatsuya
    Tateishi, Ryosuke
    Wake, Taijiro
    Nishibatake, Mizuki
    Nakagomi, Ryo
    Sato, Masaya
    Uchino, Koji
    Enooku, Kenichiro
    Nakagawa, Hayato
    Asaoka, Yoshinari
    Shiina, Shuichiro
    Koike, Kazuhiko
    HEPATOLOGY, 2017, 66 : 760A - 761A
12345